---
search:
  boost: 1
---

# Systemic Immunomodulators

![image](https://user-images.githubusercontent.com/122046056/227432531-9525f7ae-bd0f-4647-80a5-8d39ac9fa10f.png)


By Chris for 1/2023 UPDL: Immunodoluators by Dx.xlsx

***No Preferred agents with the indication for the treatment of Giant Cell Arteritis (Actemra) or Alopecia (Olumiant)***

![image](https://user-images.githubusercontent.com/122046056/231225880-900f8774-246f-49fa-98c4-4e21592430d3.png)



STATE OF WEST VIRGINIA DEPARTMENT OF HEALTH AND HUMAN RESOURCES BUREAU FOR MEDICAL SERVICES
![image](https://user-images.githubusercontent.com/122046056/227432723-27775567-311d-45e2-8976-88f7127f99bb.png)

Possible First Line Agents by Diagnosis (Provided by Brian Johnson/Chris Nguyen)
![image](https://user-images.githubusercontent.com/122046056/227432845-397db003-13f5-4c7c-a07b-448c72ad5118.png)

This is the link for [Journal of the American Academy of Dermatology - Guidelines of care for the management of atopic dermatitis](https://www.jaad.org/article/S0190-9622(14)01257-2/fulltext#secsectitle0010){ :target="_blank" rel="noopener"}
â€“ RCarpenter RPH
